Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Aike
- Development stage
- Unknown
01
Overview
**Aike** is not a unique drug identity. It is a marketed trade-name stem used for multiple distinct products in different markets, including Glacia Life Care products such as paracetamol oral suspension, mefenamic acid + paracetamol oral suspension, aceclofenac + paracetamol tablets, and aceclofenac + paracetamol + serratiopeptidase tablets. A separate Chinese product listed as AiKe has been associated with megestrol acetate. Because these products have different active ingredients, mechanisms, formulations, indications, and manufacturers, the unqualified name cannot be assigned to one specific pharmaceutical substance.
- Brand names
- Aike
Beyond the preview
Go deeper on Aike.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Aike.